NCT02818465View on ClinicalTrials.gov

Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 30, 2015

Primary Completion Date

November 16, 2017

Study Completion Date

November 16, 2017

Conditions
Hemodialyzed Patients
Interventions
OTHER

Vascular calcifications by Xray

OTHER

Vascular calcifications by tomodentimetry

BIOLOGICAL

Blood sample withdrawn

Trial Locations (1)

51092

Chu de Reims, Reims

All Listed Sponsors
lead

CHU de Reims

OTHER

NCT02818465 - Role of the Interaction Between Advanced Glycation End Products and Their Receptor RAGE in the Development and the Progression of the Uremic Vasculopathy of Hemodialyzed Patients | Biotech Hunter | Biotech Hunter